Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (17)

Competencies in radiation oncology: A new approach for education and training of professionals for Radiotherapy and Oncology in Europe

Journal article
DOI:

10.1016/j.radonc.2012.03.006
Source: Self-asserted source
Jesper Grau Eriksen

Detection of TP53 mutations by denaturing high-performance liquid chromatography

Journal article
DOI:

10.1038/86976
Source: Self-asserted source
Jesper Grau Eriksen

Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients

Journal article
DOI:

10.1016/j.radonc.2007.04.021
Source: Self-asserted source
Jesper Grau Eriksen

Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

Journal article
DOI:

10.1016/S1470-2045(10)70035-8
Source: Self-asserted source
Jesper Grau Eriksen

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials

Journal article
DOI:

10.3109/0284186X.2011.592650
Source: Self-asserted source
Jesper Grau Eriksen

Esthesioneuroblastoma: What is the Optimal Treatment?

Journal article
DOI:

10.1080/028418600430833
Source: Self-asserted source
Jesper Grau Eriksen

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

Journal article
DOI:

10.1016/j.radonc.2009.10.008
Source: Self-asserted source
Jesper Grau Eriksen

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study

Journal article
DOI:

10.1016/j.radonc.2007.05.009
Source: Self-asserted source
Jesper Grau Eriksen

Late onset of skin toxicity induced by EGFr-inhibitors

Journal article
DOI:

10.1016/j.radonc.2008.10.014
Source: Self-asserted source
Jesper Grau Eriksen

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial

Journal article
DOI:

10.1016/S1470-2045(05)70292-8
Source: Self-asserted source
Jesper Grau Eriksen

Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan

Journal article
DOI:

10.1111/j.1600-0463.2010.02631.x
Source: Self-asserted source
Jesper Grau Eriksen

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial

Journal article
DOI:

10.1016/j.radonc.2011.02.010
Source: Self-asserted source
Jesper Grau Eriksen

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times

Journal article
DOI:

10.1016/j.radonc.2005.05.004
Source: Self-asserted source
Jesper Grau Eriksen

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

Journal article
DOI:

10.1016/j.ijrobp.2003.09.043
Source: Self-asserted source
Jesper Grau Eriksen

The psychosocial work environment among physicians employed at Danish oncology departments in 2009. A nationwide cross-sectional study

Journal article
DOI:

10.3109/0284186x.2012.702926
Source: Self-asserted source
Jesper Grau Eriksen
grade
Preferred source (of 2)‎

The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma

Journal article
DOI:

10.1080/02841860510007396
Source: Self-asserted source
Jesper Grau Eriksen

Tumour hypoxia – A characteristic feature with a complex molecular background

Journal article
DOI:

10.1016/j.radonc.2006.09.005
Source: Self-asserted source
Jesper Grau Eriksen
How many people are using ORCID?